USFDA approves Zydus Lifesciences to market generic Micafungin injection

The United States Food and Drug Administration (USFDA) has given its approval to market Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials, Zydus Lifesciences Ltd said in an exchange filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/I0AcmW6
via IFTTT